Trial intelligence / Profile preview

Intravenous aminophylline for post-cesarean headache after spinal anesthesia

IRCT20190413043254N1Phase 3Completed

Sponsor
Vice Chancellor for Research, Birjand University of Medical Sciences
Start
Apr 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of aminophylline in post-dural puncture headache (PDPH) (2 arms), sponsored by Vice Chancellor for Research, Birjand University of Medical Sciences. Primary endpoint: Headache. Started Apr 2019; status: completed.

02

Drugs

aminophylline
03

Conditions

post-dural puncture headache (PDPH)

Beyond the preview

Go deeper on IRCT20190413043254N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20190413043254N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call